Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration.
about
Targeting Src family kinases in anti-cancer therapies: turning promise into triumphAssociation of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3)DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.Establishment and characterization of clear cell renal cell carcinoma cell lines with different metastatic potential from Chinese patients.STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cellsFAK inhibition abrogates the malignant phenotype in aggressive pediatric renal tumorsA randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK).Sunitinib activates Axl signaling in renal cell cancer.Abrogation of STAT3 signaling cascade by zerumbone inhibits proliferation and induces apoptosis in renal cell carcinoma xenograft mouse model.Phosphorylation of paxillin confers cisplatin resistance in non-small cell lung cancer via activating ERK-mediated Bcl-2 expression.Sodium butyrate enhances the growth inhibitory effect of sunitinib in human renal cell carcinoma cellsThe world of targeted therapies in kidney cancers: pitfalls, tips and tricks.Antcin-H Isolated from Antrodia cinnamomea Inhibits Renal Cancer Cell Invasion Partly through Inactivation of FAK-ERK-C/EBP-β/c-Fos-MMP-7 Pathways.
P2860
Q27025646-0748B261-69FE-4E74-9690-8D630AB51286Q33889920-16C26878-672F-495E-B12E-9B1BE6E51E86Q34374689-10D88659-1B14-464E-8D1B-4866D995A2D3Q36140620-7F350DCA-BB80-4D6E-881F-8BAA9E734431Q36690968-1A07F06E-BFA8-4E59-B569-5E4A57ABCFBAQ37404757-5AE10C82-D199-4A23-A513-D281E5C5EC26Q37707278-F3CE9AB4-30CC-4E33-BF9B-2D3ACD168969Q38382541-BB0ADD85-5248-4812-ADC5-E65AF51273E8Q38451761-53ED5E98-4233-47CA-8E2D-DB2BA528F8D4Q38998445-93FB054B-3725-4C99-BB6A-9681D2D846CEQ39085744-793F7058-6D54-443E-89C5-3DCFB5F05B11Q40979307-1AF15087-6792-4614-83AE-CA210E371F44Q41991580-1C284A82-342D-4CA1-9F81-85511C198410Q47131124-AB97FDA4-8FEB-4ADC-B2C4-B23C8454456C
P2860
Simultaneous targeting of Src kinase and receptor tyrosine kinase results in synergistic inhibition of renal cell carcinoma proliferation and migration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Simultaneous targeting of Src ...... a proliferation and migration.
@en
Simultaneous targeting of Src ...... a proliferation and migration.
@nl
type
label
Simultaneous targeting of Src ...... a proliferation and migration.
@en
Simultaneous targeting of Src ...... a proliferation and migration.
@nl
prefLabel
Simultaneous targeting of Src ...... a proliferation and migration.
@en
Simultaneous targeting of Src ...... a proliferation and migration.
@nl
P2093
P2860
P356
P1476
Simultaneous targeting of Src ...... a proliferation and migration.
@en
P2093
Christopher P Evans
Hsing-Jien Kung
Joon-ha Ok
Joy C Yang
Lanfang Bai
Philip C Mack
P2860
P304
P356
10.1002/IJC.26303
P577
2011-09-14T00:00:00Z